Nuzenio

Severe Alopecia Areata

Severe Alopecia Areata news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

ICYMI: EU Approves Upadacitinib for Severe Alopecia as US Review Remains Pending - Dermatology TimesDermatology Times · Thu, 06 Aug 2026 13:39:20 GMTQTTB: Bempikibart shows strong efficacy and safety in severe alopecia areata, supporting Phase 3 advancement - TradingViewTradingView · Wed, 05 Aug 2026 11:39:41 GMTLilly Korea marks expanded treatment access for dermatology and immunology patients - koreabiomed.comkoreabiomed.com · Fri, 31 Jul 2026 03:04:16 GMTAbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMTAbbVie Secures EU Approval for Rinvoq to Treat Severe Alopecia Areata - YahooYahoo · Wed, 29 Jul 2026 07:00:00 GMTEU first to clear AbbVie's Rinvoq for alopecia areata - pharmaphorumpharmaphorum · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Thu, 06 Aug 2026 13:39:20 GMTICYMI: EU Approves Upadacitinib for Severe Alopecia as US Review Remains Pending - Dermatology Times
Wed, 05 Aug 2026 11:39:41 GMTQTTB: Bempikibart shows strong efficacy and safety in severe alopecia areata, supporting Phase 3 advancement - TradingView
Fri, 31 Jul 2026 03:04:16 GMTLilly Korea marks expanded treatment access for dermatology and immunology patients - koreabiomed.com
Wed, 29 Jul 2026 07:00:00 GMTAbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata - Yahoo Finance
Wed, 29 Jul 2026 07:00:00 GMTAbbVie Secures EU Approval for Rinvoq to Treat Severe Alopecia Areata - Yahoo
Wed, 29 Jul 2026 07:00:00 GMTEU first to clear AbbVie's Rinvoq for alopecia areata - pharmaphorum

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Severe Alopecia Areata.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.